Citations

Showing 10 of 108104 citations.

Immediate and Delayed Procedural Stroke or Death in Stenting Versus Endarterectomy for Symptomatic Carotid Stenosis
Müller, Mandy D. , Felten, Stefanie von , Becquemin, Jean‐Pierre , Brown, Martin M. , Bulbulia, Richard , Calvet, David, Fraedrich, Gustav , Hendrikse, Jeroen , Gregson, John , Howard, George , Jansen, Olav , Mas, Jean‐Louis , Brott, Thomas G. , Bonati, Leo H. , Howard, George , Algra, Ale , Eckstein, Hans‐Henning , Halliday, Alison , Ringleb, Peter Arthur

Mayo Clinic

Stroke | October 15, 2018 | Volume: 49 | Issue: 11 | Pages: 2715-2722

10.1161/strokeaha.118.020684 | PMID 30355202 Get It

Background and Purpose— Stenting for symptomatic carotid stenosis (carotid artery stenting [CAS]) carries a higher risk of procedural stroke or death than carotid endarterectomy (CEA). It is unclear whether this extra risk is present both on the day of procedure and within 1 to 30 days thereafter and whether clinical risk factors differ between these periods. Methods— We analyzed the risk of stroke or death occurring on the day of procedure (immediate procedural events) and within 1 to 30 days thereafter (delayed procedural events) in 4597 individual patients with symptomatic carotid stenosis who underwent CAS (n=2326) or CEA (n=2271) in 4 randomized trials. Results— Compared with CEA, patients treated with CAS were at greater risk for immediate procedural events (110 versus 42; 4.7% versus 1.9%; odds ratio, 2.6; 95% CI, 1.9–3.8) but not for delayed procedural events (59 versus 46; 2.5% versus 2.0%; odds ratio, 1.3; 95% CI, 0.9–1.9; interaction P =0.006). In patients treated with CAS, age increased the risk for both immediate and delayed events while qualifying event severity only increased the risk of delayed events. In patients treated with CEA, we found no risk factors for immediate events while a higher level of disability at baseline and known history of hypertension were associated with delayed procedural events. Conclusions— The increased procedural stroke or death risk associated with CAS compared with CEA was caused by an excess of events occurring on the day of procedure. This finding demonstrates the need to enhance the procedural safety of CAS by technical improvements of the procedure and increased operator skill. Higher age increased the risk for both immediate and delayed procedural events in CAS, mechanisms of which remain to be elucidated. Clinical Trial Registration— URL: https://clinicaltrials.gov . Unique identifier: NCT00190398. URL: http://www.isrctn.com . Unique identifier: ISRCTN57874028. URL: http://www.isrctn.com . Unique identifier: ISRCTN25337470. URL: https://clinicaltrials.gov . Unique identifier: NCT00004732.
Late-onset Lennox-Gastaut syndrome
Cascino, Gregory D. , Smith, Kelsey M. , Britton, Jeffrey W.

Mayo Clinic

Neurology Clinical Practice | October 15, 2018 | Volume: 8 | Issue: 5 | Pages: 397-402

10.1212/cpj.0000000000000527 | PMID 30564493 Get It

Performance assessment of active vs passive pixel x‐ray angiography detector systems using a bias‐corrected channelized Hotelling observer and adult patient‐equivalent experimental conditions
Fetterly, Kenneth A.

Mayo Clinic

Medical Physics | October 13, 2018 | Volume: 45 | Issue: 11 | Pages: 4888-4896

10.1002/mp.13192 | PMID 30315578 Get It

PurposeElectronic noise associated with passive pixel (PP) x‐ray angiography flat panel detectors is known to compromise fluoroscopic image quality. An active pixel (AP) crystalline silicon x‐ray detector with potential for reduced influence of electronic noise is commercially available. The purpose of this work was to compare the performance of the AP vs PP x‐ray angiography detectors over a detector target dose (DTD) range relevant for invasive cardiology procedures.MethodsA total of 16 passive pixel detector systems representing two models and two active pixel detector systems of a single model were tested. Iodine contrast (160 mg I ml−1) disk‐shaped test objects of diameter 0.5–4.0 mm were embedded in 30 × 30 cm2 25‐cm‐thick PMMA phantom. Detector target dose was 6, 18, and 120 nGy and 1204 test signal present and signal absent images were acquired. A channelized Hotelling observer statistical model (CHO) was used to estimate detectability index (d′) of the detectors for the various test objects. The CHO included correction for bias from finite sampling and that due to temporally variable electronic noise.ResultsDetectability index estimates demonstrated similar performance between the two models of PP detectors and relatively improved performance for the AP detectors for all DTD levels and test object diameters. For DTD = 120 nGy and the 4.0 mm test object, d′ of the AP detectors was 13% and 20% greater than that of the PP detectors. For DTD = 6 nGy, d′ of the AP detectors was 42% and 54% greater.ConclusionsThe AP x‐ray angiography detector demonstrated superior performance throughout the DTD range tested and especially for DTD consistent with low‐dose fluoroscopy. The improved performance of the AP detectors may facilitate reduced patient dose and/or improved image quality.
Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative
Veitch, Dallas P. , Weiner, Michael W. , Aisen, Paul, Cairns, Nigel J., Harvey, Danielle , Jack, Clifford R. , Jagust, William J. , Morris, John C. , Petersen, Ronald C. , Shaw, Leslie M. , Toga, Arthur W. , Trojanowski, John Q. , Initiative, Alzheimer's Disease Neuroimaging, Levey, Allan I. , Kantarci, Kejal , Fox, Nick C. , Mathis, Chester A. , Thompson, Paul M. , Donohue, Michael , DeCarli, Charles , Preda, Adrian , Carrillo, María C. , Turner, Raymond Scott , Bartha, Robert , Arfanakis, Konstantinos , Lamar, Melissa , DeCarli, Charles , Jack, Clifford R , Preda, Adrian , Toga, Arthur W , Thompson, Paul M , Kantarci, Kejal , Fox, Nick C , Morris, John C , Donohue, Michael C , Harvey, Danielle J , Beckett, Laurel , Green, Robert C. , Saykin, Andrew J. , Initiative, Alzheimer's Disease Neuroimaging, Levey, Allan I , Jimenez‐Maggiora, Gustavo Adolfo

Mayo Clinic

Alzheimer's & Dementia | October 13, 2018 | Volume: 15 | Issue: 1 | Pages: 106-152

10.1016/j.jalz.2018.08.005 | PMID 30321505 Get It

Abstract Introduction The overall goal of the Alzheimer's Disease Neuroimaging Initiative (ADNI) is to validate biomarkers for Alzheimer's disease (AD) clinical trials. ADNI is a multisite, longitudinal, observational study that has collected many biomarkers since 2004. Recent publications highlight the multifactorial nature of late‐onset AD. We discuss selected topics that provide insights into AD progression and outline how this knowledge may improve clinical trials. Methods We used standard methods to identify nearly 600 publications using ADNI data from 2016 and 2017 (listed in Supplementary Material and searchable at http://adni.loni.usc.edu/news‐publications/publications/ ). Results (1) Data‐driven AD progression models supported multifactorial interactions rather than a linear cascade of events. (2) β‐Amyloid (Aβ) deposition occurred concurrently with functional connectivity changes within the default mode network in preclinical subjects and was followed by specific and progressive disconnection of functional and anatomical networks. (3) Changes in functional connectivity, volumetric measures, regional hypometabolism, and cognition were detectable at subthreshold levels of Aβ deposition. 4. Tau positron emission tomography imaging studies detailed a specific temporal and spatial pattern of tau pathology dependent on prior Aβ deposition, and related to subsequent cognitive decline. 5. Clustering studies using a wide range of modalities consistently identified a “typical AD” subgroup and a second subgroup characterized by executive impairment and widespread cortical atrophy in preclinical and prodromal subjects. 6. Vascular pathology burden may act through both Aβ dependent and independent mechanisms to exacerbate AD progression. 7. The APOE ε4 allele interacted with cerebrovascular disease to impede Aβ clearance mechanisms. 8. Genetic approaches identified novel genetic risk factors involving a wide range of processes, and demonstrated shared genetic risk for AD and vascular disorders, as well as the temporal and regional pathological associations of established AD risk alleles. 9. Knowledge of early pathological changes guided the development of novel prognostic biomarkers for preclinical subjects. 10. Placebo populations of randomized controlled clinical trials had highly variable trajectories of cognitive change, underscoring the importance of subject selection and monitoring. 11. Selection criteria based on Aβ positivity, hippocampal volume, baseline cognitive/functional measures, and APOE ε4 status in combination with improved cognitive outcome measures were projected to decrease clinical trial duration and cost. 12. Multiple concurrent therapies targeting vascular health and other AD pathology in addition to Aβ may be more effective than single therapies. Discussion ADNI publications from 2016 and 2017 supported the idea of AD as a multifactorial disease and provided insights into the complexities of AD disease progression. These findings guided the development of novel biomarkers and suggested that subject selection on the basis of multiple factors may lower AD clinical trial costs and duration. The use of multiple concurrent therapies in these trials may prove more effective in reversing AD disease progression.
Acute pancreatitis-induced takotsubo cardiomyopathy and cardiogenic shock treated with a percutaneous left ventricular assist device
Koop, Andree , Bailey, Ryan E. , Lowman, Philip, Koop, Andree H , Lowman, Philip E

Mayo Clinic

BMJ Case Reports | October 13, 2018 | Volume: 2018 | Issue: No issue available | Pages: bcr-2018-225877

10.1136/bcr-2018-225877 | PMID 30317201 Get It

A 63-year-old man was admitted for severe acute pancreatitis. On day 3 of hospitalisation, he developed shortness of breath and acute pulmonary oedema. Echocardiogram revealed global hypokinesis with a left ventricular ejection fraction of 20%, and he was diagnosed with takotsubo cardiomyopathy. He developed cardiogenic shock which was treated successfully with a percutaneous left ventricular assist device. His left ventricular ejection fraction improved by hospital follow-up 3 weeks later.
Early initiation of venovenous extracorporeal membrane oxygenation in a mechanically ventilated patient with severe acute respiratory distress syndrome
Raiker, Nisha, Cajigas, Héctor

Mayo Clinic

BMJ Case Reports | October 13, 2018 | Volume: 2018 | Issue: No issue available | Pages: bcr-2018-226223

10.1136/bcr-2018-226223 | PMID 30317205 Get It

A 49-year-old man presented to the emergency department with acute-onset dyspnoea and hypoxaemia 1 day following nasal surgery for obstructive sleep apnoea. A chest X-ray showed diffuse bilateral pulmonary infiltrates. Supplemental 100% fractional inspired oxygen (FiO2) via non-rebreather mask was delivered with resulting arterial oxygen tension:FiO2 ratio of 67. Transthoracic echocardiogram demonstrated normal heart function. A clinical diagnosis of severe acute respiratory distress syndrome (ARDS) was promptly made. Based on patient preference to avoid intubation and following a multidisciplinary approach, we decided to initiate venovenous extracorporeal membrane oxygenation (VV-ECMO) as an alternative strategy to mechanical ventilation. Though he ultimately required brief mechanical ventilation during ECMO cannulation, the patient spent a total of 5 days on VV-ECMO and a total of 8 days in the intensive care unit. Six days after discharge, his pulmonary function test demonstrated no significant abnormalities. We present a rare case of early initiation of VV-ECMO in a patient with severe ARDS that served as a bridge to recovery.
Incidence, predictors, management and outcomes of coronary perforations
Shaukat, Arslan , Tajti, Péter , Sandoval, Yader , Stanberry, Larissa , Garberich, Ross , Burke, M. Nicholas , Gössl, Mario , Henry, Timothy D. , Sorajja, Paul , Nicholas Burke, M , Sorajja, Paul , Brilakis, Emmanouil S , Mooney, Michael R , Traverse, Jay H. , Bradley, Steven M. , Brilakis, Emmanouil S.

Mayo Clinic

Catheterization and Cardiovascular Interventions | October 12, 2018 | Volume: 93 | Issue: 1 | Pages: 48-56

10.1002/ccd.27706 | PMID 30312992 Get It

AbstractObjectivesWe examined the contemporary incidence, types, predictors, angiographic characteristics, management and outcomes of coronary perforation.BackgroundCoronary perforation is a rare, but important, complication of percutaneous coronary intervention (PCI). There is lack of data on perforations stratified as large and distal vessel perforations.MethodsRetrospective, observational cohort study of all patients who underwent PCI at a high volume, tertiary hospital between the years 2009 and 2016. Angiograms of all coronary perforation cases were reviewed to determine the mechanism, type, and management of perforation. Risk‐adjusted periprocedural complication rates were compared between patients with and without coronary perforation. One‐year mortality outcomes of patients with large vessel vs. distal vessel perforation were also examined.ResultsCoronary perforation occurred in 68 of 13,339 PCIs (0.51%) performed during the study period: 51 (75%) were large vessel perforations and 17 (25%) distal vessel perforations. Most (67%) large vessel perforations were due to balloon/stent inflation, whereas most (94%) distal vessel perforations were due to guidewire exit. Patients with coronary perforations had significantly higher risk for periprocedural complications (adjusted odds ratio 7.57; 95% CI: 4.22–13.50; P < 0.001). Only one patient with large vessel perforation required emergency cardiac surgery, yet in‐hospital mortality was high with both large vessel (7.8%) and distal vessel (11.8%) perforations.ConclusionsCoronary perforation is an infrequent, but potentially severe PCI complication. Most coronary perforations are large vessel perforations. Although coronary perforations rarely lead to emergency cardiac surgery, both distal vessel and large vessel perforations are associated with high in‐hospital mortality, highlighting the importance of prevention.
Leisure‐time physical activity sustained since midlife and preservation of cognitive function: The Atherosclerosis Risk in Communities Study
Palta, Priya, Sharrett, A. Richey, Evenson, Kelly R. , Gabriel, Kelley Pettee , Folsom, Aaron R. , Gross, Alden L. , Windham, B. Gwen , Heiss, Gerardo , Deal, Jennifer A. , Knopman, David S. , Mosley, Thomas H.

Mayo Clinic

Alzheimer's & Dementia | October 12, 2018 | Volume: 15 | Issue: 2 | Pages: 273-281

10.1016/j.jalz.2018.08.008 | PMID 30321503 Get It

Abstract Introduction We tested the hypotheses that higher levels of and persistence of midlife leisure‐time physical activity (LTPA) are associated long‐term with lower cognitive decline and less incident dementia. Methods A total of 10,705 participants (mean age: 60 years) had LTPA (no, low, middle, or high) measured in 1987‐1989 and 1993‐1995. LTPA was assessed in relation to incident dementia and 14‐year change in general cognitive performance. Results Over a median follow‐up of 17.4 years, 1063 dementia cases were observed. Compared with no LTPA, high LTPA in midlife was associated with lower incidence of dementia (hazard ratio [95% confidence interval], 0.71 [0.61, 0.86]) and lower declines in general cognitive performance (−0.07 standard deviation difference [−0.12 to −0.04]). These associations were stronger when measured against persistence of midlife LTPA over 6 years. Discussion LTPA is a readily modifiable factor associated inversely with long‐term dementia incidence and cognitive decline.
Medical Cannabis, Synthetic Marijuana Extracts, and Obstructive Sleep Apnea
Ramar, Kannan , Kirsch, Douglas B. , Carden, Kelly A., Rosen, Ilene M. , Malhotra, Raman K.

Mayo Clinic

Journal of Clinical Sleep Medicine | October 12, 2018 | Volume: 14 | Issue: 10 | Pages: 1815-1816

10.5664/jcsm.7412 | PMID 30353829 Get It

Napping characteristics and cognitive performance in older adults
Owusu, Jocelynn T. , Wennberg, Alexandra , Holingue, Calliope , Tzuang, Marian , Abeson, Kylie, Spira, Adam P. , Wennberg, Alexandra M V

Mayo Clinic

International Journal of Geriatric Psychiatry | October 12, 2018 | Volume: 34 | Issue: 1 | Pages: 87-96

10.1002/gps.4991 | PMID 30311961 Get It

ObjectivesTo determine the association of napping intention, frequency, and duration with cognition in a nationally‐representative sample of US older adults.MethodsWe performed a cross‐sectional analysis of community‐dwelling Medicare beneficiaries aged ≥65 years from Rounds 3 or 4 (2013‐2014) of the National Health and Aging Trends Study (N = 2549). Participants reported past‐month napping intention (intentional/unintentional), napping frequency (rarely/never [non‐nappers], some days [infrequent nappers], most days/every day [frequent nappers]), and average nap duration (we categorized as ≤30 minutes [short]; 31‐60 minutes [moderate]; and > 60 minutes [long]). Cognitive outcomes were performance on immediate and delayed word recall tests (IWR and DWR, respectively), the Clock Drawing Test (CDT), and self‐rated memory (score: 1[excellent]‐5[very poor]).ResultsAfter adjustment for potential confounders, unintentional nappers had poorer immediate word recall test performance than non‐nappers (B = −0.23, P < 0.01) and intentional nappers (B = −0.26, P < 0.01). After further adjustment for daytime sleepiness, frequent nappers reported poorer self‐rated memory than non‐nappers (B = 0.14, P < 0.05). Compared with short nappers, long nappers had poorer IWR (B = −0.26, P < 0.05) and CDT scores (B = −0.17, P < 0.05). Except for the association of nap duration with IWR and CDT, these associations remained after excluding participants with dementia and/or proxy respondents. Among participants undiagnosed with dementia or proxies, moderate‐duration naps were associated with better DWR than short naps (B = 0.24, P < 0.05). Neither napping intentionality nor frequency was associated with CDT performance.ConclusionsAmong older adults, distinct aspects of napping are associated with cognitive performance. Prospective research, with objective measures of napping, is needed to elucidate the link between napping and cognitive trajectories.